18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in <i>IDH1/2</i> -Mutant Gliomas Treated with IDH Inhibitors
These results highlight the potential of ¹⁸F-DOPA-PET and advanced MRI sequences as valuable complements to standard RANO 2.0 MRI evaluations for assessing treatment response in glioma patients undergoing IDHi therapy.
Authors
- K Hoang-Xuan
- Alice Laurenge (ORCID: https://orcid.org/0000-0002-0058-3176)
- M. Touat
- M. Sanson (ORCID: https://orcid.org/0000-0002-1813-8476)
- Francesca Branzoli (ORCID: https://orcid.org/0000-0001-9792-0492)
- Lucia Nichelli (ORCID: https://orcid.org/0009-0006-0934-5365)
- Ángel Escamilla-Ramírez (ORCID: https://orcid.org/0000-0002-7240-3437)
- Julien Savatovsky
- Julian Jacob (ORCID: https://orcid.org/0000-0003-3156-475X)
- Louisa Drouiche
- Ahmed Idbaih
- Diego Prost
- Laura Rozenblum
- Bertrand Mathon
- Caroline Dehais
- Franck Bielle
Institutions
- Brigham and Women's Hospital (US)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Laboratoire d’Imagerie Biomédicale (FR)
- Pitié-Salpêtrière Hospital (FR)
- Ramsay Santé Hôpital privé des Peupliers (FR)
- Fondation de Rothschild (FR)
- Institut de Psychiatrie et Neurosciences de Paris (FR)
- Hôpital Charles-Foix (FR)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1158/1078-0432.ccr-25-0279
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00